CAG
24
-3
AMAT
33
-13
RRC
52
-6
HRL
35
-3
ICE
59
-3
COST
57
-6
LUV
45
-2
NVDA
52
-5
CNP
54
10
EXC
54
3
HPE
44
-2
XEL
67
2
DD
53
-6
AIZ
82
2
VZ
44
4
URBN
48
-6
HAL
48
-3
GOOGL
48
-5
HST
39
-3
TRIP
50
-4
CAG
24
-3
AMAT
33
-13
RRC
52
-6
HRL
35
-3
ICE
59
-3
COST
57
-6
LUV
45
-2
NVDA
52
-5
CNP
54
10
EXC
54
3
HPE
44
-2
XEL
67
2
DD
53
-6
AIZ
82
2
VZ
44
4
URBN
48
-6
HAL
48
-3
GOOGL
48
-5
HST
39
-3
TRIP
50
-4
Financhill
Back

Bicycle Therapeutics PLC Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
25

BCYC
Bicycle Therapeutics PLC

Last Price:
21.62
Seasonality Move:
24.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Bicycle Therapeutics PLC Price Quote

$21.62
-0.17 (-0.78%)
(Updated: November 18, 2024 at 9:45 AM ET)

Bicycle Therapeutics PLC Key Stats

Sell
25
Bicycle Therapeutics PLC (BCYC) is a Sell
Day range:
$21.27 - $22.71
52-week range:
$13.07 - $28.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
30.42
P/B ratio:
1.81%
Volume:
325.3K
Avg. volume:
456.5K
1-year change:
41.59%
Market cap:
$1.5B
Revenue:
$27M
EPS:
$-3.29

How Much Does Bicycle Therapeutics PLC Make?

Is Bicycle Therapeutics PLC Growing As A Company?

Bicycle Therapeutics PLC Stock Price Performance

What Is Bicycle Therapeutics PLC 52-Week High & Low?

Bicycle Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bicycle Therapeutics PLC?

Is Bicycle Therapeutics PLC Cash Flow Positive?

  • What Is BCYC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$202.6M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $519.9M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$918K

Bicycle Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    BCYC return on invested capital is -27.99%
  • What Is Bicycle Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -21.68%
  • What Is BCYC Return On Equity?
    ROE is a measure of profitability and is -29.19%

Bicycle Therapeutics PLC Earnings Date & Stock Price

Bicycle Therapeutics PLC Competitors

Bicycle Therapeutics PLC Dividend Yield

Bicycle Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.46%
Revenue: -50% -61.8%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 37.82
Upside from Last Price: 73.56%

Major Shareholders

  • How many BCYC shares are owned by institutional investors?
    54.9M BCYC shares are owned by institutional investors
  • How many BCYC shares are owned by insiders?
    1.1M BCYC shares are owned by insiders